Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons

Journal of Neuroscience

Volumn 17, Issue 13, 1997, Pages 4994-5003

  Miller, Karen K ^a   Hoffer, Alan ^a   Svoboda, Kurt R ^a   Lupica, Carl R ^a,b,c  

^a Department of Pharmacology ^*  (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Electrophysiology; Epilepsy; Hippocampus; Leak conductance; Neuropeptides; Potassium channel

Indexed keywords

4 AMINOPYRIDINE; CHOLECYSTOKININ; NEUROPEPTIDE; TETRODOTOXIN;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; ENZYME ACTIVITY; IMMUNOREACTIVITY; INTERNEURON; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; VOLTAGE CLAMP;

EID: 0030951921     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-13-04994.1997     Document Type: Article

References (31)

1. Bergles DE, Doze VA, Madison DV, Smith SJ (1996) Excitatory action of norepinephrine on multiple classes of hippocampal CA1 interneurons. J Neurosci 16:572-585.
2. Boden PR, Hill RG (1988) Effects of cholecystokinin and pentagastrin on rat hippocampal neurons maintained in vitro. Neuropeptides 12:95-103.
3. Bohme G, Stutzmann J, Blanchard J (1988) Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with central- or B-type CCK receptors. Brain Res 451:309-318.
4. Bohme G, Durieux C, Stutzmann J, Charpentier B, Roques BP, Blanchard J (1989) Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors. Peptides 10:407-414.
5. Branchereau P, Champagnat J, Denavit-Saubie M (1993) Cholecystokinin gated currents in neurons of the rat solitary complex in vitro. J Neurophysiol 70:2584-2595.
6. + currents in cultured rat hippocampal neurons. Neurosci Lett 107:162-166.
7. Burazin TCD, Gundlach AL (1996) Rapid but transient increases in cholecystokinin mRNA levels in cerebral cortex following amygdaloidkindled seizures in rats. Neurosci Lett 209:65-68.
8. Cobb SR, Buhl ER, Halasy K, Paulsen O, Somogyi P (1995) Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 372:75-78.
9. + conductance. J Neurophysiol 74:990-1000.
10. Crawley JN (1985) Comparative distribution of cholecystokinin and other neuropeptides. Ann NY Acad Sci 448:1-7.
11. Dockray GJ (1987) Cholecystokinin in the brain. In: Brain peptides update (Martin JB, Brownstein MJ, Krieger DT, eds), pp 127-140. New York: Wiley.
12. Dodd J, Kelly JS (1981) The actions of cholecystokinin and related peptides on pyramidal neurons of the mammalian hippocampus. Brain Res 205:337-350.
13. Dodt H-U, Zieglgansberger W (1990) Visualizing unstained neurons in living brain slices by infrared DIC microscopy. Brain Res 537:333-336.
14. Freund TF, Buzsáki G (1996) Interneurons of the hippocampus. Hippocampus 6:347-470.
15. Greenwood RS, Godar SE, Reaves Jr TA, Hayward JN (1981) Cholecystokinin in hippocampal pathways. J Comp Neurol 203:335-350.
16. Gulyas AI, Gores T, Freund TF (1993) Innervation of different peptidecontaining neurons in the hippocampus by GABAergic septal afferents. Neuroscience 37:31-44.
17. Gulyas AI, Hajos N, Freund TF (1996) Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J Neurosci 16:3397-3411.
18. Hays SE, Beinfeld MC, Jensen RT, Goodwin FK, Paul SM (1980) Demonstration of a putative receptor site for cholecystokinin in rat brain. Neuropeptides 1:53-62.
19. Iadarola MJ, Shin C, McNamara JO, Yang HY (1986) Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling. Brain Res 365:185-191.
20. Innis RB, Snyder SH (1980) Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci USA 77:6917-6922.
21. Jaffe D, Aitken P, Nadler J (1987) The effects of cholecystokinin and cholecystokinin antagonists on synaptic function in the CA1 region of the rat hippocampal slice. Brain Res 415:197-203.
22. Jarvis CR, Bourque CW, Renaud LP (1992) Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro. J Physiol (Lond) 458:621-632.
23. Kadar T, Pesti A, Peuke B (1984) Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptide and their fragments in rats after intracerebroventricular administration. Neuropharmacology 23:955-961.
24. Kosaka T, Kosaka K, Tateishi K, Hamaoka Y, Yanaihara N, Wu J-Y, Hama K (1985) GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus. J Comp Neurol 239:420-430.
25. ++ levels in a pituitary cell line. Peptides 14:801-805.
26. Lee Y, Beinborn M, McBride EW, Lu M, Kolakowski LF, Kopin AS (1993) The human brain cholecystokinin-B/gastrin receptor. J Biol Chem 268:8164-8169.
27. Mutt V (1988) Secretin and cholecystokinin. In: Gastrointestinal hormones (Mutt V ed), pp 251-320. San Diego: Academic.
28. 3H]γ-aminobutyric acid release in slices from various brain areas. Eur J Pharmacol 250:423-430.
29. Rehfeld JF, Hansen HF, Marley PD, Stengaard-Pederson K (1985) Molecular forms of cholecystokinin in the brain and relationship to neuronal gastrins. Ann NY Acad Sci 448:11-12.
30. Wu T, Wang H (1996b) Gαq/11 Mediates cholecystokinin activation of the cationic conductance in rat substantia nigra dopaminergic neurons. J Neurochem 66:1060-1066.
31. Zarbin MA, Innis RB, Wamsley JK, Snyder SH, Kuhar MJ (1983) Autoradiographic localization of cholecystokinin receptors in rodent brain. J Neurosci 3:877-906.